Synbiotech

Founded: 2012 • Age: 14 yrs Listed
Developer of probiotic products and technologies for food and animal applications

About Synbiotech

Synbiotech is a company founded in 2012. Synbiotech offers products and services including Probiotic Products and Food Application Raw Materials.

Key Metrics
  • Annual Revenue
    $1.04 B
    4.97
    as on Dec 31, 2025
  • Net Profit
    $175.97 M
    3.43
    as on Dec 31, 2025
  • EBITDA
    $277.49 M
    -2.78
    as on Dec 31, 2025

Products & Services of Synbiotech

Synbiotech offers a comprehensive portfolio of products and services, including Probiotic Products and Food Application Raw Materials.

Probiotic Products
Health Supplements

Probiotic products are developed for human health applications, including supplements and functional foods

Food Application Raw Materials
Food Ingredients

Raw materials derived from lactic acid bacteria are supplied for food applications to enhance nutritional value

Apps and channels of Synbiotech

its YouTube channel SynbioTech has 492 subscribers and 30 videos.

SynbioTech
YouTube 492 subscribers 30 videos Science & Technology
Open channel

Videos from Synbiotech

The most watched videos on Synbiotech's YouTube channel, SynbioTech (492 subscribers). Click a video to play it here.

SYNTEK™ Technology, Custom Probiotic service, and Our Manufacturing Excellence
336.4K views
20250408生合生物上櫃前業績發表會
853 views
Krunchy Kefir™ – A Revolution in Probiotic Texture
389 views
TWK10: Great Strain, Great Muscle
288 views

More on SynbioTech.

IPO & Listings of Synbiotech

Synbiotech is a publicly listed company on the TPEX with ticker symbol 1295 in Taiwan, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date13 Dec 2023
  • Listed onTT: 1295
  • Listed entitySynbio Tech Inc
  • Exchange sectorCommercial services
  • ISINTW0001295004
  • Share price50.10 TWD (-0.2% on the day) · 2026-10-08
  • Market capitalisation1,883,749,980.00 TWD
  • Price to earnings12.2
  • EPS (diluted, trailing year)4.11 TWD
  • Dividend yield5.97%
  • Volume (last session)63,964

Financials of Synbiotech

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
20251.04B TWD176.0M TWD277.5M TWD
2024989.5M TWD170.1M TWD285.4M TWD
2023823.3M TWD113.3M TWD219.8M TWD
2022739.3M TWD92.5M TWD178.8M TWD
2021855.8M TWD160.0M TWD258.5M TWD

Balance sheet, profit and loss, cash flow and ratios of , are on its company page.

Premium access

Detailed financial statements for Synbiotech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Synbiotech

The website of Synbiotech (synbiotech.com) receives about 2.9K visits a month and ranks #4,120,806 among all websites worldwide, #4,623 in Alternative and Natural Medicine.

  • Monthly visits
    2.9K

    ▼ 8.2% vs previous month

  • Unique visitors
    1.2K

    per month

  • Global rank
    #4,120,806

    among all websites

  • Category rank
    #4,623

    Health · Alternative and Natural Medicine

Similar websites

Websites whose visitors overlap most with Synbiotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
benedlife.com
100%
80.1K#409,165View details
glac.com.tw
100%
1.4K#8,798,046View details
smilerx.com.tw
smilerx.com.tw
100%
–#945,043–
skyrich.com.tw
skyrich.com.tw
68%
–#6,443,545–
healthmetaverse.com.tw
healthmetaverse.com.tw
64%
–#1,102,486–

Similar companies to Synbiotech

10 companies that operate in the same segment as Synbiotech (Traditional Health & Nutrition), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United States–USD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United States–USD 5.1 B13,500
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.
1901Petah Tikva, Central District, IsraelUSD 500 MUSD 18.74 B51,792
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, India–USD 508.93 M5,180
Pharmaceutical products are developed and marketed globally.
2009Montville, New Jersey, United StatesUSD 155.92 M––
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, India–USD 6.21 B25,870
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations
1991Delhi, Delhi, IndiaUSD 367.2 MUSD 1.52 B21,320
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt.
1967Mumbai, Maharashtra, India–USD 353.53 M3,410
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Synbiotech

Synbiotech was founded in 2012.

Synbiotech was founded in 2012 and operates in the biotechnology sector, focusing on probiotic solutions for food and animal uses. High-count probiotic ingredients, dietary supplements, and fermentation agents are produced. Services include applications for food processing and sustainable animal farming, with emphasis on antibiotic-free methods. Production processes are optimized, and packaging is designed to maintain product stability and efficacy.

Synbiotech offers Probiotic Products and Food Application Raw Materials.

Yes, Synbiotech is publicly traded on TPEX under the ticker symbol 1295.

Synbiotech operates through ,.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available